Today: 15 May 2026
Indian Stocks Log Worst Month Since 2020 as Sensex, Nifty Tumble and Rupee Breaches 95
30 March 2026
2 mins read

Indian Stocks Log Worst Month Since 2020 as Sensex, Nifty Tumble and Rupee Breaches 95

MUMBAI, March 30, 2026, 16:40 IST

Indian equities wrapped up their bleakest month since March 2020 on Monday. The Sensex slid 2.22% to settle at 71,947.55, while the Nifty 50 retreated 2.14% to 22,331.4 as crude surged above $115 a barrel amid the escalating Middle East conflict. That finish pushed the Sensex to depths not seen in over two years. The rupee crossed 95 against the dollar for the first time, marking a third consecutive day of historic lows.

India brings in roughly 90% of its oil, making it especially vulnerable when crude prices climb—higher costs can quickly push up inflation, blow out the current-account deficit, and put the squeeze on company profits. Monday wrapped up the 2025-26 fiscal year for trading, with markets closed Tuesday for a holiday.

Both benchmarks tumbled over 11% in March, capping off their worst fiscal year since 2020. Losses hit every corner: all 16 major sectors slid last month, mid-caps dropped 10.9%, small-caps 10.2%. Indian benchmarks also underperformed other Asian and emerging-market indexes.

Oil took the biggest toll. Brent advanced roughly 3% to $115.98 on Monday, tallying a sharp 60% surge for the month as the conflict—ongoing since late February—widened and rattled nerves over major supply routes. The contract briefly hit $116.70, just shy of a new 52-week peak.

Banks piled on further pressure after the Reserve Bank of India moved Friday to cap net open rupee positions at $100 million by April 10. That tighter leash sharply limits unhedged FX exposure. Financials slumped 15.6% in March. Traders steeled themselves for banks to unwind sizable basis trades linking the onshore and offshore rupee.

The rupee couldn’t hold its early gains, slipping to 95.21-95.24 per dollar on Monday. Barclays analysts noted the RBI’s intervention might offer some short-term relief, but flagged persistent risks from oil prices, capital outflows, and mounting stress on India’s external accounts.

Foreign investors didn’t stop pulling out. On Friday, provisional data had them dumping 4,367 crore rupees of Indian stocks, pushing this fiscal year’s equity outflow to $19.3 billion. That’s a big reason Indian shares have trailed their regional peers, even after the broader selloff.

Analysts aren’t calling a bottom just yet. “It’s too early to be bottom-fishing,” said Sat Duhra, portfolio manager at Henderson Far East Income, pointing out that India remains pricey compared with some North Asian markets. VK Vijayakumar, chief investment strategist at Geojit Investments, put it this way: valuations have reached “fair” territory, but, in his words, they’re “not yet cheap.” Reuters

Jefferies’ Mahesh Nandurkar flagged a risk: if the Hormuz disruption drags into April, earnings for oil marketing firms, airlines, cement, tiles, paints and adhesives could drop more than 10%. He added that GDP growth for FY2027 might end up 50 basis points—so, half a percentage point—lower, with corporate earnings trimmed by 2% to 2.5%.

Any sign of de-escalation could offer some relief. Pakistan has announced plans to host “meaningful talks” in the coming days, raising hopes of easing tensions—and maybe some pressure off oil. Still, if crude doesn’t budge from current levels or if supply lines tighten, India could be looking at the new fiscal year saddled with a weaker rupee, higher import bills, and mounting stress on banks, bonds, and rate-sensitive sectors as trading picks up again Wednesday. Moneycontrol

Safe spots were scarce. Coal India led the Nifty 50 in March, climbing 4.6% as traders moved into energy stocks. Autos and consumer durables, though, slid over 12% apiece. IT giants Tata Consultancy Services, Infosys, and Wipro all landed among the fiscal year’s laggards.

Stock Market Today

  • Expert Warns of Risks in Roth IRA Conversion for High-Balance Accounts
    May 15, 2026, 10:50 AM EDT. A financial expert cautions investors with large IRA or 401(k) balances that converting to a Roth IRA could be a costly mistake. Roth conversions involve transferring funds from a traditional retirement account to a Roth IRA, triggering immediate tax liabilities. The expert advises considering alternative strategies to manage tax impact and optimize retirement savings. This advice is crucial for those facing significant tax bills upon conversion, aiming to maximize long-term wealth retention.

Latest articles

Plug Power Stock Drops Again: The $5 Billion Hydrogen Turnaround Faces Its Cash Test

Plug Power Stock Drops Again: The $5 Billion Hydrogen Turnaround Faces Its Cash Test

15 May 2026
Plug Power shares fell 1.7% to $3.725 in early Nasdaq trading Friday, following a volatile week after first-quarter results. The company reported a 22% revenue increase to $163.5 million and improved gross margin, but its net loss widened to $245.3 million and operating cash use rose to $150 million. Plug ended March with $802 million in cash and expects $142 million from a hydrogen asset sale in June.
Why Ford Motor Company Stock Is Sliding After Its AI Data Center Rally

Why Ford Motor Company Stock Is Sliding After Its AI Data Center Rally

15 May 2026
Ford shares dropped 7% to $13.43 in early Friday trading, reversing part of a rally sparked by the launch of its new Ford Energy unit. The subsidiary, announced this week, will sell large battery energy storage systems to utilities and data centers, with first deliveries expected in late 2027. CEO Jim Farley said Ford is in the contracting phase with several customers. The stock had surged 13% Wednesday after Morgan Stanley highlighted the business.
Biogen Closes Apellis Deal; APLS Leaves Nasdaq As $5.6 Billion Rare-Disease Bet Begins

Biogen Closes Apellis Deal; APLS Leaves Nasdaq As $5.6 Billion Rare-Disease Bet Begins

15 May 2026
Biogen has closed its acquisition of Apellis Pharmaceuticals, making Apellis a wholly owned subsidiary and delisting its shares from Nasdaq. Apellis shareholders receive $41 per share in cash plus a contingent value right tied to Syfovre sales. Biogen gains the drugs Empaveli and Syfovre, and expands into kidney disease. Biogen borrowed $2 billion to help finance the deal.
Nokia Oyj Stock Pulls Back After AI Rally: What Investors Need to Know

Nokia Oyj Stock Pulls Back After AI Rally: What Investors Need to Know

15 May 2026
Nokia’s U.S.-listed shares dropped about 5% Friday, trading at $13.74 after a recent AI-driven surge. The decline followed a rally sparked by Cisco’s report of $5.3 billion in AI infrastructure orders from hyperscalers. Nokia saw a 54% jump in first-quarter operating profit and named Siemens’ Emma Falck as president of Mobile Infrastructure, effective September 1.
Ciena Corporation Stock Swings After Insider Sale Filing as AI Networking Boom Gets Tested
Previous Story

Ciena Corporation Stock Swings After Insider Sale Filing as AI Networking Boom Gets Tested

Nvidia Stock Hits 7-Year Valuation Low Even as New AI Orders Roll In
Next Story

Nvidia Stock Hits 7-Year Valuation Low Even as New AI Orders Roll In

Go toTop